U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07521722) titled 'DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community' on March 30.
Brief Summary: The DIV-AD study aims to find out whether levels of Alzheimer's disease markers in blood differ among the main ethnical groups living in central Barcelona.
It will also examine how factors such as age, income, education, and health conditions may affect these levels.
In addition, the study will identify barriers that may make it difficult to use these blood tests in primary care.
The final goal is to help ensure that everyone in Barcelona has fair access to early prevention strategies for Alzheimer's disease.
Study Start Dat...